The research lab comprises of the following members:
Dr Sourav Taru Saha (PhD)
SSourav Saha obtained his PhD in Molecular and Cell Biology (2019), where he focused on investigating a cholesterol depleting compound for treatment of breast cancer. Along with Prof Kaur, Sourav filed a provisional patent for this study based on the in vitro and in vivo results. He also delved into the molecular mechanisms of this cholesterol-depletor via protein and gene expression studies along with drug-protein interactions. Sourav is currently working as a clinical fellow at the University of Toronto
Dr Bernice Monchusi (PhD)
Bernice Monchusi was previously employed as a postdoctoral fellow in Kaur’s lab. She is involved in several projects relating to cancer drug resistance. Her main project focuses on exploring the role of miRNAs in cholesterol-mediated drug resistance, in breast cancer. Currently, she is a postdoctoral fellow at the University of Limpopo focusing of screening medicinal plants for bioactive compounds with anti-cancer, anti-metastatic, anti-inflammatory, and anti-diabetic properties. She is involved in procurement, supervision, co-supervision, and teaching of postgraduate students. Bernice is an enthusiastic, vibrant and joyful individual, it is always a pleasure working with her.
Dr Farhat Khan (PhD)
Farhat Khan completed her PhD in Molecular and cell biology in 2022, under the supervision of Prof. Mandeep Kaur. Her focused area was in the field of Applied Bioinformatics, where she aimed at creating the first-ever manually curated Inflammatory bowel disease (IBD) genes database and utilized bioinformatics tools to develop key biomarkers which can serve as potential diagnostic measure to predict early risk of colorectal cancer in IBD patients.
Dr Gabriella Palma (PhD)
Gabriella worked diligently to obtain her doctorate at the beginning of 2023. During her MSc studies, Gabriella was interested in uncovering the potential of novel compounds to reduce breast cancer-related drug resistance, where she created a novel resistant cell line for investigation. Gabriella elaborated upon this research during her PhD, showing particular interest in the role of miRNAs in regulating cholesterol-mediated drug resistance in breast cancer. She assumed the additional responsibility of managing lab ongoings. Gabriella is currently working as a medical area manager at L'Oreal South Africa and is anticipated to continue growing in her success.